Biotech RadarJobs updated

COMPANY

Yarrow Bioscience

HQ: New Haven, CT source · yarrowbioscience.com ↗

Clinical Phase 2

Location: New Haven, CT · source · Sep 14, 2026

Profile checked Oct 10, 2026

Keywords: Graves' Disease Experimental: YB-101

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 2: Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT07682896Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' DiseasePhase 2RecruitingJun 10, 20262027-12 (estimated)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Feedback